Enzymes modify drugs into their active and inactive metabolites. A person's genetic makeup may seriously affect how well certain enzymes perform.
RESPONSE™ acts as a lifelong prescribing roadmap, steering the provider towards drugs that are metabolized efficiently and away from those that are not.
RESPONSE™ acts as a safeguard, protecting both physician and patient from undesirable adverse drug reactions.
RESPONSE™ flags potentially dangerous interactions between drugs and often suggests suitable alternatives.
A lifelong prescribing roadmap that will steer the provider toward drugs that are metabolized efficiently and away from those that are not.
A safeguard, protecting both physician and patient from undesirable, adverse drug reactions and potentially dangerous drug-drug interactions.
In cases of potential adverse drug reactions or unfavorable drug-drug interactions, RESPONSE™ often suggests suitable alternatives.
Patients that experience less than optimal results from prescribed medications.
Patients with a personal or family history of adverse drug reactions in response to certain medications.
Patients taking multiple prescribed medications for multiple chronic conditions.
FDA studies estimate that 7% of hospitalized patients have a serious adverse drug reaction with a fatality rate of 0.32%.
There are more than 2,216,000 serious ADRs in hospitalized patients, causing over 106,000 deaths annually.